Skip to main content

BY4 (Primaquine Phosphate 15mg (base))

Pill with imprint BY4 is Purple, Round and has been identified as Primaquine Phosphate 15mg (base). It is supplied by Bayshore Pharmaceuticals, LLC.

Primaquine is used in the treatment of pneumocystis pneumonia; malaria; malaria prevention and belongs to the drug class antimalarial quinolines. FDA has not classified the drug for risk during pregnancy. Primaquine 15mg (base) is not a controlled substance under the Controlled Substances Act (CSA).

Images for BY4

Primaquine Phosphate

Imprint
BY4
Strength
15mg (base)
Color
Purple
Shape
Round
Availability
Prescription only
Drug Class
Antimalarial quinolines
Pregnancy Category
N - Not classified
CSA Schedule
Not a controlled drug
Labeler / Supplier
Bayshore Pharmaceuticals, LLC
National Drug Code (NDC)
60429-0035
Inactive Ingredients
microcrystalline cellulose, corn starch, lactose monohydrate, magnesium stearate, water, titanium dioxide, FD&C Red No. 40, FD&C Blue No. 2

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related images for "BY4"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.